Exhibit 4.1


 


Form of Representative’s Warrant
to Purchase Ordinary Shares


 


THE REGISTERED HOLDER OF THIS PURCHASE WARRANT BY ITS ACCEPTANCE
HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS PURCHASE WARRANT EXCEPT AS HEREIN PROVIDED AND THE REGISTERED HOLDER
OF THIS PURCHASE WARRANT AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR HYPOTHECATE THIS PURCHASE WARRANT OR CAUSE IT
TO BE THE SUBJECT OF ANY HEDGING, SHORT SALE, DERIVATIVE, PUT, OR CALL TRANSACTION THAT WOULD RESULT IN THE EFFECTIVE ECONOMIC
DISPOSITION OF THIS PURCHASE WARRANT BY ANY PERSON FOR A PERIOD OF ONE HUNDRED EIGHTY (180) DAYS BEGINNING ON THE DATE OF COMMENCEMENT
OF SALES OF THE OFFERING (DEFINED BELOW) TO ANYONE OTHER THAN (I) VIEWTRADE SECURITIES, INC. OR AN UNDERWRITER OR A SELECTED DEALER
IN CONNECTION WITH THE OFFERING, OR (II) A BONA FIDE OFFICER OR PARTNER OF VIEWTRADE SECURITIES, INC. OR OF ANY SUCH UNDERWRITER
OR SELECTED DEALER AND IN ACCORDANCE WITH FINRA RULE 5110(E)(2).


 


THIS PURCHASE WARRANT IS VOID AFTER 5:00
P.M., EASTERN TIME, [●].1


 


PURCHASE WARRANT


 


For the Purchase of [●] Ordinary
Shares

of

UTIME LIMITED


 


1. Purchase Warrant. THIS CERTIFIES THAT, pursuant to that certain Underwriting Agreement, dated [●], 2021
(the “Underwriting Agreement”), by and between UTime Limited (the “Company”), and
ViewTrade Securities, Inc., as representative of the underwriters named on Annex A thereto, providing for the initial public
offering (the “Offering”) of ordinary shares, par value $0.0001 per share, of the Company (the “Ordinary
Shares”), ViewTrade Securities, Inc. or its assigns (“Holder”), as registered owner of this Purchase
Warrant, is entitled, at any time or from time to time on or after [●] (the “Commencement Date”)2,
and at or before 5:00 p.m., Eastern time, [●]3 (the “Expiration Date”), but not thereafter,
to subscribe for, purchase and receive, in whole or in part, up to [●]4 Ordinary Shares (the “Shares”),
subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are
authorized by law or executive order to close, then this Purchase Warrant may be exercised on the next succeeding day which is
not such a day in accordance with the terms herein. During the period commencing on the date hereof and ending on the Expiration
Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially
exercisable at $[●] per Share5; provided, however, that upon the occurrence of any of the
events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the
number of Shares to be received upon such exercise, shall be adjusted as therein specified. This Purchase Warrant is being issued
pursuant to the Underwriting Agreement providing for the Offering. The term “Effective Date” shall mean the
effective date of the registration statement in connection with the Offering. The term “Exercise Price” shall
mean the initial exercise price or the adjusted exercise price, depending on the context.


 





 






1 Date that is five years from the Effective Date.


2 Applicable Closing Date.


3 Date that is five years from the Effective Date.


4 10% of the Shares sold in the Offering at the
applicable Closing Date.


5 125% of the price of the Shares sold in the Offering
at the applicable Closing Date.



 






     


     


    

 


2.
Exercise.


 


2.1
Exercise Form. In order to exercise this Purchase Warrant, the exercise form attached hereto must be duly executed
and completed and delivered to the Company, together with this Purchase Warrant and payment of the Exercise Price for the Shares
being purchased payable in cash by wire transfer of immediately available funds to an account designated by the Company or by certified
check or official bank check to the order of the Company. If the subscription rights represented hereby shall not be exercised
at or before 5:00 p.m., Eastern time, on the Expiration Date, this Purchase Warrant shall become and be void without further force
or effect, and all rights represented hereby shall cease and expire.


 


2.2
Cashless Exercise. At any time after the Commencement Date, in lieu of exercising this Purchase Warrant by payment
of cash or check payable to the order of the Company pursuant to Section 2.1 above, Holder may elect to receive the number
of Shares equal to the value of this Purchase Warrant (or the portion thereof being exercised) by surrender of this Purchase Warrant
to the Company, together with the exercise form attached hereto, in which event the Company shall issue to Holder Shares in accordance
with the following formula:


 


Y(A-B)


X    =           A


 


Where,


 


X = The number of Shares to be issued to Holder;


Y = The number of Shares that
would be issuable upon exercise of this Purchase Warrant if such exercise were by means of a cash exercise pursuant to Section
2.1 rather than a cashless exercise pursuant to this Section 2.2;


A = The fair market value of one
Share, as determined in accordance with the provisions of this Section 2; and


B = The Exercise Price in effect
under this Purchase Warrant at the time the election to exercise this Purchase Warrant on a cashless basis is made pursuant to
this Section 2.


 


For purposes of this
Section 2.2, the fair market value of a Share is defined as follows:


 


(i)    
if the Ordinary Shares are traded on a national securities exchange, the fair market value shall be deemed to be the closing
sales price on such exchange on the Trading Day immediately prior to the date the exercise form is submitted to the Company in
connection with the exercise of this Purchase Warrant; or


 


(ii)
if the Ordinary Shares are traded over-the-counter (i.e., on the OTCQB or OTCQX Markets operated by OTC Markets Group, Inc.,
or any similar over-the-counter market), the fair market value shall be deemed to be the closing bid price on the Trading Day immediately
prior to the date the exercise form is submitted to the Company in connection with the exercise of this Purchase Warrant; or


 


(iii)    
if there is no active public market for the Ordinary Shares, the value shall be the fair market value thereof, as determined
in good faith by the Company’s Board of Directors.


 


“Trading Day”
means a date on which the Ordinary Shares are traded on the NYSE, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq
Global Select Market, the New York Stock Exchange or the OTC Bulletin Board (or any successors to any of the foregoing).


 






    	 	2	 



     


    

 


For the avoidance of
doubt, if there is no effective registration statement registering, or no current prospectus available for, the resale of the Shares
underlying this Purchase Warrant by the Holder, then this Purchase Warrant may be exercised, in whole or in part, at such time
by means of a cashless exercise in accordance with the provisions of this Purchase Warrant.


 


2.3
Mechanics of Exercise.


 


(i)    
Issuance of Shares Upon Exercise. The Company shall use commercially reasonable efforts to cause the Shares purchased
hereunder to be issued by the Company and certificates (if any) to be transmitted by the Transfer Agent to the Holder by crediting
the account of the Holder’s prime broker with The Depository Trust Company through its Deposit or Withdrawal at Custodian
system (“DWAC”) if the Company is then a participant in such system and either (A) there is an effective registration
statement permitting the issuance of the Shares or resale of the Shares or (B) this Purchase Warrant is being exercised via cashless
exercise, and otherwise by delivery to the address specified by the Holder in the Notice of Exercise by the date that is two Trading
Days after the latest of (A) the delivery to the Company of the Notice of Exercise, (B) surrender of this Purchase Warrant (if
required) and (C) receipt by the Company of the aggregate Exercise Price as set forth above (including by cashless exercise, if
permitted) (such date, the “Share Delivery Date”). The Shares shall be deemed to have been issued, and the Holder
or any other person so designated to be named therein shall be deemed to have become a holder of record of such Shares for all
purposes, as of the date the Purchase Warrant has been exercised and payment to the Company of the aggregate Exercise Price (or
by cashless exercise, if permitted) has been received by the Company and all taxes required to be paid by the Holder, if any, pursuant
to Section 2.3(vi) prior to the issuance of such Shares have been paid.


 


(ii)
Delivery of New Warrants Upon Exercise. If this Purchase Warrant shall have been exercised in part, the Company shall,
at the written request of the Holder and upon surrender of this Purchase Warrant, at the time of issuance of the Shares, deliver
to the Holder a new Purchase Warrant evidencing the rights of the Holder to purchase the unpurchased Shares called for by this
Purchase Warrant, which new Purchase Warrant shall in all other respects be identical with this Purchase Warrant.


 


(iii)    
Rescission Rights. If the Company fails to cause its transfer agent to transmit to the Holder the Shares pursuant
to Section 2.3(i) by the Share Delivery Date, unless such failure was not caused by the fault or negligence of the Company,
then the Holder will have the right to rescind such exercise upon written notice to the Company within one Trading Day after the
Share Delivery Date.


 


(iv)    
Compensation for Buy-In on Failure to Timely Issue Shares Upon Exercise. In addition to any other rights available
to the Holder, if the Holder has taken all actions necessary under the terms of this Purchase Warrant for such Holder to receive
the Shares, if the Company fails to cause the Transfer Agent to transmit to the Holder the Shares pursuant to an exercise on or
before the Share Delivery Date, unless such failure was not caused by the fault or negligence of the Company, and if after such
date the Holder is required by its broker to purchase (in an open market transaction or otherwise) or the Holder’s brokerage
firm otherwise purchases, Ordinary Shares to issue in satisfaction of a sale by the Holder of the which the Holder anticipated
receiving upon such exercise (a “Buy-In”), then the Company shall (A) pay in cash to the Holder the amount,
if any, by which (x) the Holder’s total purchase price (including brokerage commissions and any other applicable fees, if
any) for the Ordinary Shares so purchased exceeds (y) the amount obtained by multiplying (1) the number of Shares that the Company
was required to issue to the Holder in connection with the exercise at issue times (2) the price at which the sell order giving
rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the portion of the Purchase
Warrant and equivalent number of Shares for which such exercise was not honored (in which case such exercise shall be deemed rescinded)
or issue to the Holder the number of Ordinary Shares that would have been issued had the Company timely complied with its exercise
and issuance obligations hereunder. For example, if the Holder purchases Ordinary Shares having a total purchase price of $11,000
to cover a Buy-In with respect to an attempted exercise of Shares with an aggregate sale price giving rise to such purchase obligation
of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The
Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon
request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder’s right to pursue any other
remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or
injunctive relief with respect to the Company’s failure to timely issue Ordinary Shares upon exercise of the Purchase Warrant
as required pursuant to the terms hereof.


 






    	 	3	 



     


    

 


(v)  No Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon
the exercise of this Purchase Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon
such exercise, the Company shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount
equal to such fraction multiplied by the Exercise Price or round up to the next whole share.


 


(vi)
Charges, Taxes and Expenses. Issuance of Shares shall be made without charge to the Holder for any issue or transfer
tax or other incidental expense in respect of the issuance of such Shares, all of which taxes and expenses shall be paid by the
Company, and such Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; provided,
however, that, in the event Shares are to be issued in a name other than the name of the Holder, this Purchase Warrant when
surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company
may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The
Company shall pay all transfer agent fees required for same-day processing of any Notice of Exercise.


 


3. Transfer - General
Restrictions. The Holder agrees by his, her or its acceptance hereof, that such Holder will not: (a) sell, transfer, assign,
pledge or hypothecate this Purchase Warrant, or the securities issuable hereunder, for a period of one hundred eighty (180) days
beginning on the date of commencement of sales of the Offering to anyone other than: (i) ViewTrade Securities, Inc. or another
underwriter or a selected dealer participating in the Offering, or (ii) a bona fide officer or partner of ViewTrade Securities,
Inc. or of any such underwriter or selected dealer, in each case in accordance with FINRA Rule 5110(e)(1) and subject to the exceptions
set forth in FINRA Rule 5110(e)(2), or (b) cause this Purchase Warrant or the securities issuable hereunder to be the subject
of any hedging, short sale, derivative, put or call transaction that would result in the effective economic disposition of this
Purchase Warrant or the securities hereunder, in accordance with FINRA Rule 5110(e)(1) and except as provided for in FINRA Rule
5110(e)(2). One hundred eighty (180) days after the date of commencement of sales of the Offering, transfers to others may be
made subject to compliance with or exemptions from applicable securities laws. In order to make any permitted assignment, the
Holder must deliver to the Company the assignment form attached hereto duly executed and completed, together with this Purchase
Warrant and payment of all transfer taxes, if any, payable in connection therewith. The Company shall within five (5) business
days transfer this Purchase Warrant on the books of the Company and shall execute and deliver a new Purchase Warrant or Purchase
Warrants of like tenor to the appropriate assignee(s) expressly evidencing the right to purchase the aggregate number of Shares
purchasable hereunder or such portion of such number as shall be contemplated by any such assignment. The Company shall register
this Purchase Warrant, upon records to be maintained by the Company for that purpose (the “Warrant Register”),
in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder of this Purchase
Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
purposes, absent actual notice to the contrary.


 


4.
Registration. The Company shall be required to keep a registration statement effective on Form F-1 (or Form
F-3, if the Company is eligible to use such form) until such date that is the earlier of the date when all of the Shares underlying
this Purchase Warrant have been publicly sold by the Holder or such time as Rule 144 or another similar exemption under the Securities
Act of 1933, as amended, is available for the sale of all of such Holder’s Shares underlying this Purchase Warrant without
limitation during a three-month period without registration.


 






    	 	4	 



     


    

 


5.
New Purchase Warrants to be Issued.


 


5.1
Partial Exercise or Transfer. Subject to the restrictions in Section 3 hereof, this Purchase Warrant may be
exercised or assigned in whole or in part. In the event of the exercise or assignment hereof in part only, upon surrender of this
Purchase Warrant for cancellation, together with the duly executed exercise or assignment form and funds sufficient to pay any
Exercise Price and/or transfer tax if exercised pursuant to Section 2 hereto, the Company shall cause to be delivered to
the Holder without charge a new Purchase Warrant of like tenor to this Purchase Warrant in the name of the Holder evidencing the
right of the Holder to purchase the number of Shares purchasable hereunder as to which this Purchase Warrant has not been exercised
or assigned.


 


5.2
Replacement on Loss. Upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction
or mutilation of this Purchase Warrant, the Company, at its own expense, shall execute and deliver a new Purchase Warrant of like
tenor and date. Any such new Purchase Warrant executed and delivered as a result of such loss, theft, mutilation or destruction
shall constitute a substitute contractual obligation on the part of the Company.


 


6.
Adjustments.


 


6.1
Adjustments to Exercise Price and Number of Shares. The Exercise Price and the number of Shares underlying this Purchase
Warrant shall be subject to adjustment from time to time as hereinafter set forth:


 


6.1.1
Share Capitalizations; Share Sub-Divisions etc. If, after the date hereof, and subject to the provisions of Section
6.3 below, the number of issued and outstanding Ordinary Shares is increased by a share capitalization of Ordinary Shares or
by a sub-division of Ordinary Shares, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar
transaction, then, on the effective day thereof, the number of Shares purchasable hereunder shall be increased in proportion to
such increase in issued and outstanding Ordinary Shares, and the Exercise Price shall be proportionately decreased. Any adjustment
made pursuant to this Section 6.1.1 shall become effective immediately after the record date for the determination of shareholders
entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of
a subdivision, combination or re-classification.


 


6.1.2
Subsequent Rights Offerings. In addition to any adjustments pursuant to Section 6.1.1 above, if at any time
during which this Purchase Warrant is outstanding the Company grants, issues or sells any securities of the Company which by their
terms are convertible into or exercisable for Ordinary Shares (“Ordinary Share Equivalents”) or other rights
to purchase shares, warrants, securities or other property, pro rata to all of the record holders of the Ordinary Shares (the “Purchase
Rights”), and not the Holder, then the Holder will be entitled to acquire, upon the terms applicable to such Purchase
Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of Ordinary Shares
acquirable upon complete exercise of this Purchase Warrant immediately before the date on which a record is taken for the grant,
issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of Ordinary Shares
are to be determined for the grant, issue or sale of such Purchase Rights. The provisions of this Section 6.1.2 will not
apply to any grant, issuance or sale of Ordinary Share Equivalents or other rights to purchase shares, warrants, securities or
other property of the Company which is not made pro rata to all of the record holders of Ordinary Shares.


 






    	 	5	 



     


    

 


6.1.3
Aggregation of Shares. If, after the date hereof, and subject to the provisions of Section 6.3 below, the
number of issued and outstanding Ordinary Shares is decreased by a consolidation, combination or reclassification of Ordinary Shares
or other similar event, then, on the effective date thereof, the number of Shares purchasable hereunder shall be decreased in proportion
to such decrease in issued and outstanding Shares, and the Exercise Price shall be proportionately increased.


 


6.1.4
Replacement of Shares upon Reorganization, etc. In case of any reclassification or reorganization of the issued and
outstanding Ordinary Shares other than a change covered by Section 6.1.1, 6.1.2 or 6.1.3 hereof or that solely affects
the par value of such Ordinary Shares, or in the case of any share reconstruction or amalgamation or merger or consolidation of
the Company with or into another corporation or other entity (other than a consolidation or share reconstruction or amalgamation
in which the Company is the continuing corporation and that does not result in any reclassification or reorganization of the issued
and outstanding Ordinary Shares), or in the case of any sale or conveyance to another corporation or entity of the property of
the Company as an entirety or substantially as an entirety, or in the case any, direct or indirect, purchase offer, tender offer
or exchange offer (whether by the Company or another person) is completed pursuant to which holders of Ordinary Shares are permitted
to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or
more of the issued and outstanding Ordinary Shares, or in the case the Company, directly or indirectly, in one or more related
transactions effects any reclassification, reorganization or recapitalization of the Ordinary Shares or any compulsory share exchange
pursuant to which the Ordinary Shares are effectively converted into or exchanged for other securities, cash or property, or (in
the case the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement
or other business combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement)
with another person or group of persons, whereby such other Person or group acquires more than 50% of the issued and outstanding
Ordinary Shares (not including any Ordinary Shares held by the other Person or other Persons making or party to, or associated
or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business combination),
then the Holder of this Purchase Warrant shall have the right thereafter (until the expiration of the right of exercise of this
Purchase Warrant) to receive upon the exercise hereof, for the same aggregate Exercise Price payable hereunder immediately prior
to such event, the kind and amount of shares or other securities or property (including cash) receivable upon such reclassification,
reorganization, share reconstruction or amalgamation, or consolidation, or upon a dissolution following any such sale or transfer,
by a Holder of the number of Shares of the Company obtainable upon exercise of this Purchase Warrant immediately prior to such
event; and if any reclassification also results in a change in Shares covered by Section 6.1.1, 6.1.2 or 6.1.3,
then such adjustment shall be made pursuant to Sections 6.1.1, 6.1.2 or 6.1.3 and this Section 6.1.4.
The provisions of this Section 6.1.4 shall similarly apply to successive reclassifications, reorganizations, share reconstructions
or amalgamations, or consolidations, sales or other transfers.


 


6.1.5
Changes in Form of Purchase Warrant. This form of Purchase Warrant need not be changed because of any change pursuant
to this Section 6.1, and any Purchase Warrant issued after such change may state the same Exercise Price and the same number
of Shares as are stated in the initial Purchase Warrant. The acceptance by the Holder of the issuance of a new Purchase Warrant
reflecting a required or permissive change shall not be deemed to waive any rights to an adjustment occurring after the Commencement
Date or the computation thereof.


 






    	 	6	 



     


    

 


6.2
Substitute Purchase Warrant. In case of any consolidation of the Company with, or share reconstruction or amalgamation
of the Company with or into, another corporation or other entity (other than a consolidation or share reconstruction or amalgamation
which does not result in any reclassification or change of the issued and outstanding Ordinary Shares), the corporation or other
entity formed by such consolidation or share reconstruction or amalgamation shall execute and deliver to the Holder a supplemental
Purchase Warrant providing that the holder of each Purchase Warrant then outstanding or to be outstanding shall have the right
thereafter (until the stated expiration of such Purchase Warrant) to receive, upon exercise of such Purchase Warrant, the kind
and amount of shares and other securities and property receivable upon such consolidation or share reconstruction or amalgamation,
by a holder of the number of Shares of the Company for which such Purchase Warrant might have been exercised immediately prior
to such consolidation, share reconstruction or amalgamation, sale or transfer. Such supplemental Purchase Warrant shall provide
for adjustments which shall be identical to the adjustments provided for in this Section 6. The above provision of this
Section shall similarly apply to successive consolidations or share reconstructions or amalgamations.


 


6.3
Elimination of Fractional Interests. The Company shall not be required to issue fractions of Shares upon the exercise
of this Purchase Warrant, nor shall it be required to issue scrip or pay cash in lieu of any fractional interests, it being the
intent of the parties that all fractional interests shall be eliminated by rounding any fraction up or down, as the case may be,
to the nearest whole number of Shares or other securities, properties or rights.


 


6.4
Notice to Holder.


 


6.4.1
Adjustment to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section
6, the Company shall promptly provide the Holder with a notice setting forth the Exercise Price after such adjustment and any
resulting adjustment to the number of Shares and setting forth a brief statement of the facts requiring such adjustment.


 


6.4.2
Notice to Allow Exercise by Holder. If (A) the Company shall declare a dividend (or any other distribution in whatever
form) on the Ordinary Shares, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Ordinary
Shares , (C) the Company shall authorize the granting to all holders of the Ordinary Shares rights or warrants to subscribe for
or purchase any shares of capital equity of any class or of any rights, (D) the approval of any shareholders of the Company shall
be required in connection with any reclassification of the Ordinary Shares, any consolidation or merger to which the Company is
a party, any sale or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby
the Ordinary Shares are converted into other securities, cash or property, or (E) the Company shall authorize the voluntary or
involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall provide
the Holder with, at least 10 days prior to the applicable record or effective date hereinafter
specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption,
rights or warrants, or if a record is not to be taken, the date as of which the holders of the Ordinary Shares of record to be
entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification,
consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is
expected that holders of the Ordinary Shares of record shall be entitled to exchange their Ordinary Shares for securities, cash
or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided
that the failure to provide such notice or any defect therein or in the provision thereof shall not affect the validity of the
corporate action required to be specified in such notice. The Holder shall remain entitled to exercise this Purchase Warrant during
the period commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise
be expressly set forth herein. Notwithstanding the foregoing, no notice need be given to the Holder if the Company makes a public
announcement of the applicable event via nationally distributed press release or via a publicly available and legally compliant
filing with the U.S. Securities and Exchange Commission.


 






    	 	7	 



     


    

 


7.
Reservation and Listing; Registration Rights.


 


7.1
The Company shall at all times reserve and keep available out of its authorized Ordinary Shares, solely for the purpose
of issuance upon exercise of this Purchase Warrant, such number of Shares or other securities, properties or rights as shall be
issuable upon the exercise thereof. The Company covenants and agrees that, upon exercise of this Purchase Warrant and payment of
the Exercise Price therefor, in accordance with the terms hereby, all Shares and other securities issuable upon such exercise shall
be duly and validly issued, fully paid and non-assessable and not subject to preemptive or similar rights of any shareholder and
free and clear of all liens, taxes and charges. As long as this Purchase Warrant shall be outstanding, the Company shall use commercially
reasonable efforts to cause all Shares issuable upon exercise of this Purchase Warrant to be listed (subject to official notice
of issuance) on all national securities exchanges (or, if applicable, on the OTCQB or OTCQX Markets operated by OTC Markets Group,
Inc., or any similar over-the-counter market) on which the Shares issued to the public in the Offering may then be listed and/or
quoted.


 


7.2 To
the extent the Company does not maintain an effective registration statement for the Shares and cashless exercise is
unavailable to any Holder under Section 2.2 hereof pursuant to which all of the Shares issuable upon exercise of this
Purchase Warrant under Section 2.2 would be tradable upon exercise of this Purchase Warrant upon issuance, and in the
further event that the Company files a registration statement with the U.S. Securities and Exchange Commission to register
its Ordinary Shares (other than a registration statement on Form F-4 or S-8, or on another form, or in another context, in
which such “piggyback” registration would be inappropriate), then, for the term of this Purchase Warrant, the
Company shall give written notice of such proposed filing to the Holder as soon as practicable but in no event less than
twenty (20) days before the anticipated filing date, which notice shall describe the amount and type of securities to be
included in such offering, the intended method(s) of distribution, and the name of the proposed managing underwriter or
underwriters, if any, of the offering, and offer to the Holder in such notice the opportunity to register the sale of such
number of Shares as such Holder may request in writing within five days following receipt of such notice (a
“Piggyback Registration”). The Company shall use commercially reasonable efforts to cause such Shares to
be included in such registration and shall use commercially reasonable efforts to cause the managing underwriter or
underwriters of a proposed underwritten offering to permit the Shares requested to be included in a Piggyback Registration on
the same terms and conditions as any similar securities of the Company and to permit the sale or other disposition of such
Shares in accordance with the intended method(s) of distribution thereof. All Holders proposing to distribute their
securities through a Piggyback Registration that involves an underwriter or underwriters shall enter into an underwriting
agreement in customary form with the underwriter or underwriters selected for such Piggyback Registration. Notwithstanding
the provisions of this Section 7.2, such right to request Piggyback Registration shall terminate on the fifth anniversary of
the Effective Date, in accordance with FINRA Rule 5110(g)(8)(D).


 


8.
Certain Notice Requirements.


 


8.1
Holder’s Right to Receive Notice. Nothing herein shall be construed as conferring upon the Holder the right
to vote or consent or to receive notice as a shareholder for the election of directors or any other matter, or as having any rights
whatsoever as a shareholder of the Company. If, however, at any time prior to the expiration of this Purchase Warrant and its exercise,
any of the events described in Section 8.2 shall occur, then, in one or more of said events, the Company shall give written
notice of such event at least five (5) days prior to the date fixed as a record date or the date of closing the transfer books
(the “Notice Date”) for the determination of the shareholders entitled to such dividend, distribution, conversion
or exchange of securities or subscription rights, or entitled to vote on such proposed dissolution, liquidation, winding up or
sale. Such notice shall specify such record date or the date of the closing of the transfer books, as the case may be. Notwithstanding
the foregoing, the Company shall deliver to each Holder a copy of each notice given to the other shareholders of the Company at
the same time and in the same manner that such notice is given to the shareholders; provided, however, that the Company shall not
be obligated to provide any written notice under this Section 8 if it makes a public announcement of the applicable event
via nationally distributed press release or via a publicly available and legally compliant filing with the U.S. Securities and
Exchange Commission.


 






    	 	8	 



     


    

 


8.2
Events Requiring Notice. The Company shall be required to give the notice described in this Section 8 upon
one or more of the following events: (i) if the Company shall take a record of the holders of its shares for the purpose of entitling
them to receive a dividend or distribution payable otherwise than in cash, or a cash dividend or distribution payable otherwise
than out of retained earnings, as indicated by the accounting treatment of such dividend or distribution on the books of the Company,
(ii) the Company shall offer to all the holders of its shares any additional shares of the Company or securities convertible into
or exchangeable for shares of the Company, or any option, right or warrant to subscribe therefor, or (iii) a dissolution, liquidation
or winding up of the Company (other than in connection with a consolidation or share reconstruction or amalgamation) or a sale
of all or substantially all of its property, assets and business shall be proposed.


 


8.3
Notice of Change in Exercise Price; Notice of Exercise Price. The Company shall, within five (5) business days after
an event requiring a change in the Exercise Price pursuant to Section 6 hereof, send notice to the Holder of such event
and change (“Price Notice”). The Price Notice shall describe the event causing the change and the method of
calculating the same and shall be certified as being true and accurate by the Company’s Chief Executive Officer and Chief
Financial Officer. The Company shall, within five (5) business days after receipt by the Company of a written request by the Holder,
send notice to the Holder of the Exercise Price then in effect and the number of Shares or the amount, if any, of other shares,
securities or assets then issuable upon exercise of this Purchase Warrant and shall be certified as being true and accurate by
the Company’s Chief Executive Officer and Chief Financial Officer.


 


8.4
Transmittal of Notices. All notices, requests, consents and other communications under this Purchase Warrant shall
be in writing and shall be deemed to have been duly made when (1) hand delivered, (2) mailed by express mail or private courier
service, or (3) if sent by electronic mail, on the day the notice was sent if during regular business hours and, if sent outside
of regular business hours, on the following business day, to following addresses or to such other addresses as the Company or Holder
may designate by notice to the other party:


 


If to the Holder, to:


 


ViewTrade Securities, Inc.


7280 W. Palmetto Park Road, Suite 310


Boca Raton, FL 33433


Attention: Douglas Aguililla, Director, Investment
Banking


Email: dougagui@viewtrade.com


Facsimile: (561) 620-0302


 


with a copy to (which shall not constitute notice):


 


K&L Gates LLP


Southeast Financial Center, Suite 3900


200 South Biscayne Boulevard


Miami, Florida 33131-2399


Attention: Clayton E. Parker, Esq.


Email: Clayton.Parker@klgates.com


Facsimile: (305) 358-7095


 






    	 	9	 



     


    

 


If to the Company, to:


 


UTime Limited


7th Floor, Building 5A


Shenzhen Software Industry Base, Nanshan District


Shenzhen, People’s Republic of China 518061


Attention: Minfei Bao


Email: bminfei@utimemobile.com


 


with a copy to (which shall not constitute notice):


 


Ellenoff Grossman & Schole LLP


1345 Avenue of the Americas, 11th Floor


New York, NY 10105


Attention: Barry I. Grossman, Esq.


Email: bigrossman@egsllp.com


Facsimile: (212) 370-7889


 


9.
Miscellaneous.


 


9.1
Amendments. The Company and the Holder may from time to time supplement, modify or amend this Purchase Warrant by
a written agreement signed by the Company and the Holder. All modifications or amendments shall require the written consent of
and be signed by the party against whom enforcement of the modification or amendment is sought.


 


9.2
Headings. The headings contained herein are for the sole purpose of convenience of reference, and shall not in any
way limit or affect the meaning or interpretation of any of the terms or provisions of this Purchase Warrant.


 


9.3
Entire Agreement. This Purchase Warrant (together with the other agreements and documents being delivered pursuant
to or in connection with this Purchase Warrant) constitutes the entire agreement of the parties hereto with respect to the subject
matter hereof, and supersedes all prior agreements and understandings of the parties, oral and written, with respect to the subject
matter hereof.


 


9.4
Binding Effect. This Purchase Warrant shall inure solely to the benefit of and shall be binding upon, the Holder
and the Company and their permitted assignees, respective successors, legal representative and assigns, and no other person shall
have or be construed to have any legal or equitable right, remedy or claim under or in respect of or by virtue of this Purchase
Warrant or any provisions herein contained.


 


9.5
Governing Law; Submission to Jurisdiction; Trial by Jury. This Purchase Warrant shall be governed by and construed
and enforced in accordance with the internal laws of the State of New York, without giving effect to conflict of laws principles
thereof. The Company hereby agrees that any action, proceeding or claim against it arising out of, or relating in any way to this
Purchase Warrant shall be brought and enforced in the U.S. federal and state courts sitting in the Borough of Manhattan in the
City of New York, and irrevocably submits to such jurisdiction, which jurisdiction shall be exclusive. The Company hereby waives
any objection to such exclusive jurisdiction and that such courts represent an inconvenient forum. Any process or summons to be
served upon the Company may be served by transmitting a copy thereof by registered or certified mail, return receipt requested,
postage prepaid, addressed to it at the address set forth in Section 8.4 hereof. Such mailing shall be deemed personal service
and shall be legal and binding upon the Company in any action, proceeding or claim. The Company and the Holder agree that the prevailing
party(ies) in any such action shall be entitled to recover from the other party(ies) all of its reasonable attorneys’ fees
and expenses relating to such action or proceeding and/or incurred in connection with the preparation therefor. The Company (on
its behalf and, to the extent permitted by applicable law, on behalf of its shareholders and affiliates) and the Holder hereby
irrevocably waive, to the fullest extent permitted by applicable law, any and all right to trial by jury in any legal proceeding
arising out of or relating to this Purchase Warrant or the transactions contemplated hereby.


 






    	 	10	 



     


    

 


9.6
Waiver, etc. The failure of the Company or the Holder to at any time enforce any of the provisions of this Purchase
Warrant shall not be deemed or construed to be a waiver of any such provision, nor to in any way affect the validity of this Purchase
Warrant or any provision hereof or the right of the Company or any Holder to thereafter enforce each and every provision of this
Purchase Warrant. No waiver of any breach, non-compliance or non-fulfillment of any of the provisions of this Purchase Warrant
shall be effective unless set forth in a written instrument executed by the party or parties against whom or which enforcement
of such waiver is sought; and no waiver of any such breach, non-compliance or non-fulfillment shall be construed or deemed to be
a waiver of any other or subsequent breach, non-compliance or non-fulfillment.


 


9.7
Successors and Assigns. Subject to applicable securities laws, this Purchase Warrant and the rights and obligations
evidenced hereby shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the
successors and permitted assigns of Holder. The provisions of this Purchase Warrant are intended to be for the benefit of any Holder
from time to time of this Purchase Warrant and shall be enforceable by the Holder or holder of this Purchase Warrant.


 


9.8
Loss, Theft, Destruction or Mutilation of Warrant. The Company covenants that upon receipt by the Company of evidence
reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Purchase Warrant or any share certificate relating
to the Shares, if share certificates are issued, and in case of loss, theft or destruction, of indemnity or security reasonably
satisfactory to it (which, in the case of the Purchase Warrant, shall not include the posting of any bond), and upon surrender
and cancellation of such Purchase Warrant or share certificate, if share certificates are issued, if mutilated, the Company will
make and deliver a new Purchase Warrant or share certificate, if share certificates are issued, of like tenor and dated as of such
cancellation, in lieu of such Purchase Warrant or share certificate, if share certificates are issued.


 


9.9
Remedies. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of
damages, will be entitled to specific performance of its rights under this Purchase Warrant. The Company agrees that monetary damages
would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Purchase Warrant
and hereby agrees to waive and not to assert the defense in any action for specific performance or other equitable remedy that
a remedy at law would be adequate.


 


9.10    
Severability. Wherever possible, each provision of this Purchase Warrant shall be interpreted in such manner as to
be effective and valid under applicable law, but if any provision of this Purchase Warrant shall be prohibited by or invalid under
applicable law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder
of such provision or the remaining provisions of this Purchase Warrant.


 


9.11    
Execution in Counterparts. This Purchase Warrant may be executed in one or more counterparts, and by the different
parties hereto in separate counterparts, each of which shall be deemed to be an original, but all of which taken together shall
constitute one and the same agreement, and shall become effective when one or more counterparts has been signed by each of the
parties hereto and delivered to each of the other parties hereto. Such counterparts may be delivered by facsimile transmission
or other electronic transmission.


 


[Signature Page Follows]


 






    	 	11	 



     


    

 


IN WITNESS WHEREOF, the Company has caused
this Purchase Warrant to be signed by its duly authorized officer as of the ______ day of     .


 


	 	UTIME LIMITED
	 	 	 
	 	By:	 
	 	 	Name:
	 	 	Title:




 


Acknowledged and Agreed:


 


VIEWTRADE SECURITIES, INC.


 


	By:	 	 
	 	Name: Douglas Aguililla	 
	 	Title: Director, Investment Banking	 




 


[Signature Page to Representative’s Warrant]


 






      


     


    

 


Form
of Exercise


 


The undersigned holder
hereby exercises the right to purchase _________________ ordinary shares (“Warrant Shares”) of UTime Limited
(the “Company”), evidenced by the attached Purchase Warrant (the “Purchase Warrant”). Capitalized
terms used herein and not otherwise defined shall have the respective meanings set forth in the Purchase Warrant. Please issue
the Warrant Shares as to which the Purchase Warrant is exercised in accordance with the instructions given below and, if applicable,
a new Purchase Warrant representing the number of Warrant Shares for which the Purchase Warrant has not been exercised.


 


1. Form of Exercise
Price. The Holder intends that payment of the Exercise Price shall be made as:


 


____________a
“Cash Exercise” with respect to _________________ Warrant Shares; and/or


 


____________a
“Cashless Exercise” with respect to _______________ Warrant Shares.


 


2. Payment of
Exercise Price. In the event that the holder has elected a Cash Exercise with respect to some or all of the Warrant
Shares to be issued pursuant hereto, the holder shall pay the aggregate Exercise Price in the sum of
$     to the Company in accordance with the terms
of the Purchase Warrant.


 


3. Issuance of Warrant
Shares. The Company shall deliver to the holder __________ Warrant Shares in accordance with the terms of the Purchase Warrant.
Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:


 


_______________________________


 


The Warrant Shares shall be delivered to
the following DWAC Account Number:


 


_______________________________


 


_______________________________


 


_______________________________


 


Date: _______________ __, ______


 


	 	 
	 Name of Registered Holder	 
	 	 	 
	By:	 	 
	 	Name:	 
	 	Title:	 




 






      


     


    

 


INSTRUCTIONS FOR REGISTRATION OF SECURITIES


 


	Name:	 	 
	 	 	 
	 	(Print in Block Letters)	 
	 	 	 
	Address:	 	 
	 	 	 
	 	 	 




 


NOTICE: The signature
to this form must correspond with the name as written upon the face of the Purchase Warrant without alteration or enlargement or
any change whatsoever, and must be guaranteed by a bank, other than a savings bank, or by a trust company or by a firm having membership
on a registered national securities exchange.


 






      


     


    

 


FORM OF ASSIGNMENT


 


FOR VALUE RECEIVED, the undersigned registered
owner of this Purchase Warrant hereby sells, assigns and transfers unto the Assignee named below all of the rights of the undersigned
to purchase ordinary shares, par value $0.0001 per share, of UTime Limited (the “Company”), evidenced
by this Purchase Warrant, with respect to the number of ordinary shares set forth below.


 


	Name of Assignee	 	Address and Phone Number	 	No. of Shares
	 	 	 	 	 
	 	 	 	 	 
	 	 	 	 	 



 


The undersigned also represents that, by
assignment hereof, the Assignee acknowledges that this Purchase Warrant and the ordinary shares to be issued upon exercise hereof
or conversion thereof are being acquired for investment and that the Assignee will not offer, sell or otherwise dispose of this
Purchase Warrant or any ordinary shares to be issued upon exercise hereof or conversion thereof except under circumstances which
will not result in a violation of the Securities Act of 1933, as amended, or any state securities laws. Further, the Assignee has
acknowledged that upon exercise of this Purchase Warrant, the Assignee shall, if requested by the Company, confirm in writing,
in a form satisfactory to the Company, that the ordinary shares so purchased are being acquired for investment and not with a view
toward distribution or resale.


 


	 	 
	Signature of Holder	 
	 	 
	Date	 


 


The undersigned assignee agrees to be bound
by all of the terms and conditions of this Purchase Warrant.


 


	 	 
	Signature of Assignee	 
	 	 
	Date